Answers are grounded in this paper and cite their sources.
Adjuvants that combine TLR agonists and inflammatory agonists promote robust and durable vaccine responses (Bechtoldet al. and Arunachalamet al.).
No takes yet. Share an insight, caveat, or question.
Reed et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: